In the News / Politics

New FDA Approved Treatment in Patients With Hypoparathyroidism and Hypocalcemia

By: Dimitrios Savva, PharmD Candidate c/o 2016 - Hypoparathyroidism is a rare disease that affects approximately 60,000 people in the…

11 years ago

Seeing is Believing: A Look at VEGF Inhibitors for Diabetic Macular Edema

By: Svetlana Akbasheva, Staff Editor, PharmD Candidate c/o 2016 - Diabetes is one of the biggest health problems in the…

11 years ago

Magic Mushrooms: The Future of Smoking Cessation?

By: Maximilian Magun, PharmD Candidate c/o 2016 - While the harm in smoking is well known, quitting is easier said…

11 years ago

An Aspirin a Day? New Study Assesses Rate of Inappropriate Aspirin Use for Primary Prevention of CVD

By: Svetlana Akbasheva, Staff Writer - Aspirin 81 mg, or “baby” aspirin, has become almost ubiquitously known as being “heart-healthy”…

11 years ago

Great Promise for Factor Xa Inhibitor Antidote: Andexanet Alfa

By: Galina Perel, PharmD Candidate c/o 2016 - Andexanet alfa’s has achieved great advancement in part one of the Phase…

11 years ago

Working Towards an Artificial Pancreas

By: Maryam Ahmed and Tyler Valente, PharmD Candidates c/o 2016 - Diabetes Mellitus is a condition in which the body…

11 years ago

The Role of Pharmacists in the EVD Outbreak

By: Azia Tariq, Section Editor - Reported in March 2014, the current Ebola virus disease (EVD) outbreak has become the…

11 years ago

Injectable Naltrexone for Smoking Cessation

By: Jacqueline Meaney, PharmD Candidate c/o 2015, University at Buffalo: School of Pharmacy and Pharmaceutical Sciences - Extended release naltrexone (XR-NTX),…

11 years ago

Fifth Time’s a Charm?

Fifth Time’s a Charm? By: Sylva Ohanian, Staff Writer - Liraglutide (Saxenda®) has recently been approved by the FDA for…

11 years ago

Early Use of Antibiotics Tied to an Increased Risk of Pediatric Asthma

By: Fatima Elzin, PharmD Candidate c/o 2015 - According to the Centers for Disease Control and Prevention, the prevalence of…

11 years ago